Feature | April 03, 2017| Dave Fornell

Most Popular DAIC Content in March 2017

tryton side branch stent, dedicated coronary side branch stent

The FDA approval of the Tryton Side Branch Stent was the biggest technology news from March. It is deployed in the side branch artery using a standard single wire balloon-expandable stent delivery system. A conventional drug eluting stent is then placed in the main vessel.

April 3, 2017 — Here is the list of the top 25 most popular pieces of content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of March based on website analytics:  

1. FDA Clears First Dedicated Coronary Bifurcation Stent

2. ACC 2017 Late-Breaking Trials

3. FDA Clears Nano-coated Coronary Stent to Reduce DAPT

4. New Heart Attack Evaluation Cuts Unnecessary Tests, Time in ER

5. FDA Expands Indication for Melody Transcatheter Valve for Failed Surgical Valves

6. PCI, Drugs Equally Beneficial for Treating Fully Blocked Arteries - ACC.17

7. FDA Panel Supports Approval for First TAVR Embolic Protection Device

8. FDA Clears CoreValve Evolut Pro Transcatheter Aortic Valve

9. Collaboration by Metro Detroit Cardiologists Increases Cardiogenic Shock Survival Rate

10. VIDEO: Demonstration of the Tryton Dedicated Bifurcation Stent

11. U.K. Patent Court Rules in Edwards Lifesciences TAVR Case Against Boston Scientific

12. Benefits Shown for Treating All Clogged Arteries After a Heart Attack - ACC.17

13. Evolocumab Significantly Reduces Risk of Cardiovascular Events, LDL - ACC.17

14. TAVR Can Cause Silent Cerebral Microbleeds, Neurological Impairment - ACC.17

15. Teleflex Announces 510(k) Clearance and U.S. Launch of TrapLiner Catheter

16. Philips Launches Azurion Platform Angiography System

17. Henry Ford Hospital Study Shows 3-D Imaging Improves Fixing Broken Hearts

18. Medtronic Receives FDA Clearance for Reveal LINQ Insertable Cardiac Monitor With TruRhythm Detection

19. FDA Clears Artis Pheno Angiography System from Siemens Healthineers

20. Bioresorbable Stent Comparable to Xience at Two Year, But With Adverse Trends - ACC.17

21. Videos of Interventional Cardiac Technology Advances

22. Easier to Use iFR Equal to Outcomes of FFR in Coronary Lesion Evaluation - ACC.17

23. CT Scans Reveal Reduced Leaflet Motion After Aortic Valve Replacement - ACC.17

24. Biosensors Announces Enrollment of First Patient in New U.S. Pivotal BioFreedom Trial

25. TAVR Stands Equal to Surgical Valve Replacement - ACC.17



Most Popular DAIC Content in February 2017

Most Popular Cardiology Articles of 2016 From DAIC

Related Content

A patient who received HeartMate III LVAD system at ACC.18. The HeartMate 3 was the topic of of the the key late-breaking trials at #ACC18

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC.18. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at this year's conference.

Feature | ACC | March 27, 2018 | Dave Fornell
There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American Colle
Drug Stops Dangerous Bleeding in Patients Taking Factor Xa Inhibitors


News | ACC | March 22, 2018
March 22, 2018 — The experimental drug...
Videos | ACC | March 21, 2018
DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at
ACC 2018 Late-Breaking Trials Announced
News | ACC | March 21, 2018
Here is a list of the American College of Cardiology (ACC) 2018 annual meeting late-breaking clinical trials presente
Inhaled Therapy Ineffective in Difficult-to-Treat Heart Failure at ACC 2018.

Image from presentation, "Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF: The INDIE-HFpEF Trial," Borlaug

News | ACC | March 20, 2018
March 20, 2018 — Four weeks of treatment with a novel inhaled medication failed to improve exercise capacity, daily a
More Deaths, Strokes Seen with Perioperative Beta Blocker One Year After Surgery

Image from presentation, "1-Year outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery," Devereaux 

News | ACC | March 20, 2018
March 20, 2018 — During the 12 months after undergoing noncardiac surgery, patients with or at risk for heart disease
Trial for Gout Drug Meets Primary Endpoint, Raises Safety Concerns, image shows a CT scan showing gout in the knees.
News | ACC | March 20, 2018
March 20, 2018 — Febuxostat, a gout dr...
Canakinumab Doesn’t Prevent Prediabetes from Progressing to Diabetes according to a late-breaking study at ACC 2018.
News | ACC | March 20, 2018
March 20, 2018 — The anti-inflammatory...
Dabigatran Reduces Major Cardiovascular Complications in Patients With Myocardial Injury after Noncardiac Surgery
News | ACC | March 20, 2018
March 20, 2018 — Treatment with the blood-thinning drug dabigatran significantly reduced the risk of death, heart att
Statins May Bring Benefits at Time of Treatment for Heart Attack, Angina

Image from presentation, "Statins Evaluation in Coronary Procedures and Revascularization," Berwanger 

News | ACC | March 20, 2018
March 20, 2018 — Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broa
Overlay Init